Schuback D E, Chen Z Y, Craig I W, Breakefield X O, Sims K B
Molecular Neurogenetics Unit, Massachusetts General Hospital East, Boston 02129, USA.
Hum Mutat. 1995;5(4):285-92. doi: 10.1002/humu.1380050403.
We report our experience to date in mutation identification in the Norrie disease (ND) gene. We carried out mutational analysis in 26 kindreds in an attempt to identify regions presumed critical to protein function and potentially correlated with generation of the disease phenotype. All coding exons, as well as noncoding regions of exons 1 and 2, 636 nucleotides in the noncoding region of exon 3, and 197 nucleotides of 5' flanking sequence, were analyzed for single-strand conformation polymorphisms (SSCP) by polymerase chain reaction (PCR) amplification of genomic DNA. DNA fragments that showed altered SSCP band mobilities were sequenced to locate the specific mutations. In addition to three previously described submicroscopic deletions encompassing the entire ND gene, we have now identified 6 intragenic deletions, 8 missense (seven point mutations, one 9-bp deletion), 6 nonsense (three point mutations, three single bp deletions/frameshift) and one 10-bp insertion, creating an expanded repeat in the 5' noncoding region of exon 1. Thus, mutations have been identified in a total of 24 of 26 (92%) of the kindreds we have studied to date. With the exception of two different mutations, each found in two apparently unrelated kindreds, these mutations are unique and expand the genotype database. Localization of the majority of point mutations at or near cysteine residues, potentially critical in protein tertiary structure, supports a previous protein model for norrin as member of a cystine knot growth factor family (Meitinger et al., 1993). Genotype-phenotype correlations were not evident with the limited clinical data available, except in the cases of larger submicroscopic deletions associated with a more severe neurologic syndrome.(ABSTRACT TRUNCATED AT 250 WORDS)
我们报告了目前在诺里病(ND)基因中进行突变鉴定的经验。我们对26个家族进行了突变分析,试图确定对蛋白质功能至关重要且可能与疾病表型产生相关的区域。通过对基因组DNA进行聚合酶链反应(PCR)扩增,分析了所有编码外显子以及外显子1和2的非编码区、外显子3非编码区的636个核苷酸以及5'侧翼序列的197个核苷酸的单链构象多态性(SSCP)。对显示SSCP条带迁移率改变的DNA片段进行测序以定位特定突变。除了先前描述的三个包含整个ND基因的亚显微缺失外,我们现在还鉴定出6个基因内缺失、8个错义突变(7个点突变、1个9碱基缺失)、6个无义突变(3个点突变、3个单碱基缺失/移码突变)和1个10碱基插入,在外显子1的5'非编码区产生了一个扩展重复序列。因此,在我们迄今研究的26个家族中的24个(92%)中已鉴定出突变。除了在两个明显不相关的家族中发现的两种不同突变外,这些突变都是独特的,扩展了基因型数据库。大多数点突变位于半胱氨酸残基处或其附近,这在蛋白质三级结构中可能至关重要,支持了先前将诺里蛋白作为胱氨酸结生长因子家族成员的蛋白质模型(梅廷格等人,1993年)。根据有限的临床数据,除了与更严重神经综合征相关的较大亚显微缺失病例外,基因型与表型的相关性并不明显。(摘要截短至250字)